Aravind P Medikonda from 117 Thesda St, Arlington, MA 02474

Ligand-Directed Covalent Modification Of Protein
view source
US Patent:

20110269244, Nov 3, 2011
Filed:

Dec 30, 2010
Appl. No.:

12/982352
Inventors:

Russell C. Petter - Stow MA, US
Charles F. Jewell - Columbia MD, US
Kwangho Lee - Waltham MA, US
Aravind Prasad Medikonda - Arlington MA, US
Deqiang Niu - Lexington MA, US
Lixin Qiao - Andover MA, US
Juswinder Singh - Ashland MA, US
Zhendong Zhu - Westborough MA, US
International Classification:

G01N 33/68
G06G 7/58
C07K 1/107
US Classification:

436501, 530402, 703 11
Abstract:

The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.

Ligand-Directed Covalent Modification Of Protein
view source
US Patent:

20170218353, Aug 3, 2017
Filed:

Feb 2, 2017
Appl. No.:

15/423115
Inventors:

- Pembroke, BM
Charles F. Jewell - Columbia MD, US
Kwangho Lee - Waltham MA, US
Aravind Prasad Medikonda - Arlington MA, US
Deqiang Niu - Lexington MA, US
Lixin Qiao - Andover MA, US
Juswinder Singh - Ashland MA, US
Zhendong Zhu - Westborough MA, US
International Classification:

C12N 9/96
C12N 9/00
C12N 9/12
C12Q 1/37
C12Q 1/48
G06F 19/16
C07D 487/04
C07D 491/08
C07D 405/14
C07D 495/04
C07D 403/14
C12N 9/50
C12Q 1/25
Abstract:

The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.

Aravind P Medikonda